The Interaction of the Proposed LDC Extension Request and the 2016 Pharmaceutical Product Extension

The current request of WTO LDC Members for an unconditional extension of the time period within which they must become compliant with the TRIPS Agreement covers all forms of intellectual property protection under TRIPS.  Even though it is true that some LDCs have signed other treaties that might impose some IP obligations, e.g., the Paris [...]